Search - Prime Therapeutics

366 Results for GLP-1 Pipeline Update

Quarterly Drug Pipeline: January 2025

Cover image for Quarterly Drug Pipeline: January 2025 Updates on promising therapies in development, focusing on drugs nearing FDA approval Prime Therapeutics /quarterly-drug-pipeline-january-2025...

Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline
Quarterly Drug Pipeline: October 2024

cover image for Quarterly Drug Pipeline: October 2024 Quarterly Drug Pipeline: October 2024 Prime Therapeutics /quarterly-drug-pipeline-october-2024 Prime Therapeutics’ Quarterly Drug Pipeline...

Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline
Managed Healthcare Executive: Prime Therapeutics Finds No Medical Cost Offsets for GLP-1 Obesity Drugs | AMCP Annual 2025

Managed Healthcare Executive: A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member,...

PA Sub-Categories: GLP-1 Prime Article: In the News
AMCP 2024: Behind the GLP-1 Spotlight Session with Ben Urick

Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting

PA Sub-Categories: GLP-1 Prime Article: Stories